When real-time fMRI neurofeedback improves people's symptoms long after treatment, might that influence the guidance that's provided to patients, and also inform the design of future clinical trials? In episode 60, we're joined by Michelle Hampson from Yale University's School of Medicine. She discusses her research finding that people people suffering from neuropsychiatric disorders may benefit from real-time fMRI neurofeedback, not only while inside the brain scanners, but also for weeks afterwards.